帕金森病来源外泌体加重SNCA*A53T小鼠的神经病理
研究从帕金森病患者和健康对照血浆中用抗L1CAM包被磁珠免疫沉淀法纯化可能神经来源的细胞外囊泡,并用于Prnp-SNCAA53T转基因帕金森病小鼠模型,发现患者来源囊泡促进α-突触核蛋白病理和神经元丢失,其中novel_miR_44438通过靶向NDST1 mRNA抑制硫酸乙酰肝素功能、阻止外泌体生成和α-突触核蛋白释放。
要点
- 帕金森病患者血浆L1CAM纯化囊泡可加重SNCA*A53T小鼠α-突触核蛋白病理和神经元丢失。
- novel_miR_44438在帕金森病组显著升高,呈剂量依赖性促进α-突触核蛋白蓄积和神经元变性。
- novel_miR_44438直接靶向NDST1 mRNA并抑制硫酸乙酰肝素功能,阻止外泌体生成和α-突触核蛋白释放。
核心结论
- 帕金森病来源L1CAM纯化囊泡中的novel_miR_44438抑制神经元α-突触核蛋白外排,从而促进α-突触核蛋白的病理性蓄积和聚集。
研究设计与样本
- 从帕金森病患者和健康对照血浆中用抗L1CAM包被磁珠的免疫沉淀法纯化可能神经来源的细胞外囊泡。
- 采用Prnp-SNCAA53T转基因帕金森病小鼠模型评估帕金森病来源L1CAM纯化囊泡诱导的神经元病理。
- 用细胞外囊泡相关微小RNA谱分析筛选帕金森病来源L1CAM纯化囊泡中改变的微小RNA。
主要发现
- 帕金森病患者来源L1CAM纯化(可能神经来源)囊泡促进Prnp-SNCAA53T转基因帕金森病小鼠的α-突触核蛋白病理和神经元丢失。
- novel_miR_44438在帕金森病组显著升高,并以剂量依赖性方式促进α-突触核蛋白蓄积和神经元变性。
- novel_miR_44438直接靶向NDST1 mRNA并抑制硫酸乙酰肝素功能,从而阻止外泌体生成和α-突触核蛋白从外泌体释放。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Accumulation of α-synuclein (α-syn) in neurons is a prominent feature of Parkinson's disease (PD). Recently, researchers have considered that extracellular vesicles (EVs) may play an important role in protein exportation and propagation, and α-syn-containing EVs derived from the central nervous system (CNS) have been detected in peripheral blood. However, mechanistic insights into CNS-derived EVs have not been well-described. METHODS: Likely neurogenic EVs were purified from the plasma of PD patients and healthy controls using a well-established immunoprecipitation assay with anti-L1CAM-coated beads. A Prnp-SNCAA53T transgenic PD mouse model was used to evaluate the neuronal pathology induced by PD-derived L1CAM-purified EVs. EV-associated microRNA (miRNA) profiling was used to screen for altered miRNAs in PD-derived L1CAM-purified EVs. RESULTS: PD patient-derived L1CAM-purified (likely neurogenic) EVs facilitated α-syn pathology and neuron loss in Prnp-SNCAA53T transgenic PD mice. The miRNA, novel_miR_44438, was significantly increased in the PD group, which promoted α-syn accumulation and neuronal degeneration in a dose-dependent manner. Novel _miR_44438 directly targets NDST1 mRNA and inhibits the function of heparan sulfate, thus preventing exosome biogenesis and α-syn release from exosomes. INTERPRETATION: Novel_miR_44438 in PD-derived L1CAM-purified EVs inhibits the α-syn efflux from neurons thereby promoting the pathological accumulation and aggregation of α-syn. ANN NEUROL 2022;92:230-245.
引用
- Huang Y, Liu Z, Li N, et al. Parkinson's Disease Derived Exosomes Aggravate Neuropathology in SNCA*A53T Mice. Ann Neurol. 2022. PMID: 35596947. doi:10.1002/ana.26421
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。